Retrospective Study
Copyright ©The Author(s) 2024.
World J Psychiatry. Jun 19, 2024; 14(6): 857-865
Published online Jun 19, 2024. doi: 10.5498/wjp.v14.i6.857
Table 1 General information
Indicators
Control group (n = 55)
Research group (n = 61)
χ2/t-test
P value
Sex (male/female)35/2037/240.1090.741
Age (yr)58.00 ± 5.9758.77 ± 7.060.6310.530
CHF course (yr)3.89 ± 0.663.84 ± 0.820.3590.720
NYHA classification (II/III)31/2435/260.0120.912
Depression course (months)4.53 ± 0.774.67 ± 0.940.8720.385
Depression degree (mild/moderate)17/3820/410.0470.829
Table 2 Clinical efficacy
Indicators
Control group (n = 55)
Research group (n = 61)
χ2
P value
Marked effectiveness16 (29.09)22 (36.07)
Effectiveness27 (49.09)36 (59.02)
Ineffectiveness12 (21.82)3 (4.92)
Total effective rate43 (78.18)58 (95.08)7.3370.007